Logo image of GWPH

Gw Pharma ADR (GWPH) Stock Price, Forecast & Analysis

USA - NASDAQ:GWPH -

218.96
-0.32 (-0.15%)
Last: 5/4/2021, 8:00:01 PM
219.58
+0.62 (+0.28%)
After Hours: 5/4/2021, 8:00:01 PM

GWPH Key Statistics, Chart & Performance

Key Statistics
Market Cap6.86B
Revenue(TTM)559.04M
Net Income(TTM)-69.84M
Shares31.35M
Float28.31M
52 Week High219.57
52 Week Low87.07
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.86
PEN/A
Fwd PE326.81
Earnings (Next)02-18 2022-02-18/bmo
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


GWPH short term performance overview.The bars show the price performance of GWPH in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60 80

GWPH long term performance overview.The bars show the price performance of GWPH in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80 100

The current stock price of GWPH is 218.96 null. In the past month the price increased by 0.6%. In the past year, price increased by 101.96%.

Gw Pharma ADR / GWPH Daily stock chart

GWPH Latest News, Press Relases and Analysis

About GWPH

Company Profile

GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and neuropathic pain. It operates primarily in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc is based in Salisbury, the United Kingdom.

Company Info

Gw Pharma ADR

SOVEREIGN HOUSE VISION PARK HISTON

CAMBRIDGE X0 CB24 9BZ

CEO: Justin Gover

Phone: 44-12-2326-6800

Gw Pharma ADR / GWPH FAQ

Can you describe the business of Gw Pharma ADR?

GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and neuropathic pain. It operates primarily in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc is based in Salisbury, the United Kingdom.


Can you provide the latest stock price for Gw Pharma ADR?

The current stock price of GWPH is 218.96 null. The price decreased by -0.15% in the last trading session.


What is the dividend status of Gw Pharma ADR?

GWPH does not pay a dividend.


What is the ChartMill technical and fundamental rating of GWPH stock?

GWPH has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the Price/Earnings (PE) ratio of Gw Pharma ADR (GWPH)?

Gw Pharma ADR (GWPH) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.86).


GWPH Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to GWPH. When comparing the yearly performance of all stocks, GWPH is one of the better performing stocks in the market, outperforming 76.48% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

GWPH Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to GWPH. GWPH has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

GWPH Financial Highlights

Over the last trailing twelve months GWPH reported a non-GAAP Earnings per Share(EPS) of -1.86. The EPS decreased by -675% compared to the year before.


Industry RankSector Rank
PM (TTM) -12.49%
ROA -7.47%
ROE N/A
Debt/Equity 0.01
Chartmill High Growth Momentum
EPS Q2Q%-10.71%
Sales Q2Q%26.39%
EPS 1Y (TTM)-675%
Revenue 1Y (TTM)42.35%

GWPH Forecast & Estimates


Analysts
Analysts64.4
Price TargetN/A
EPS Next Y136.02%
Revenue Next YearN/A

GWPH Ownership

Ownership
Inst Owners0%
Ins Owners0.37%
Short Float %N/A
Short RatioN/A